Literature DB >> 26501786

Substance Use, Depression and Sociodemographic Determinants of HIV Sexual Risk Behavior in Outpatient Substance Abuse Treatment Patients.

Susan Tross1, Daniel J Feaster, Gabriel Thorens, Rui Duan, Zoilyn Gomez, Martina Pavlicova, Mei Chen Hu, Tiffany Kyle, Sarah Erickson, Anya Spector, Louise Haynes, Lisa R Metsch.   

Abstract

OBJECTIVES: The NIDA Clinical Trials Network trial of rapid HIV testing/counseling in 1281 patients was a unique opportunity to examine relationships among substance use, depressive symptoms, and sex risk behavior.
METHODS: Past 6-month substance use; substance use severity (Drug Abuse Screening Test - 10); depressive symptoms (Quick Inventory of Depressive Symptomatology); and three types of sex risk behavior (unprotected sex occasions [USOs] with primary partners; USOs with nonprimary partners; and USOs while high/drunk) were assessed. Zero-inflated negative binomial analyses provided: probability and rate of sex risk behavior (in risk behavior subsample).
RESULTS: Levels of sexual risk behavior were high, while variable across the three types of sex risk behaviors. Among the patients, 50.4% had engaged in USOs with primary partners, 42% in sex while drunk or high, and 23.8% in USOs with nonprimary partners. Similar factors were significantly associated with all three types of sex risk behaviors. For all types, problem drinking, cocaine use, and substance use severity had an exacerbating effect. Older age was associated with lower risk behavior; other relationship categories (eg, married, separated/divorced, cohabitating) were associated with greater risk behavior than was single status. Depressive symptoms were associated with decreased likelihood of USOs with a primary partner.
CONCLUSIONS: Sexual risk behavior is common among individuals in outpatient substance abuse treatment. Results highlight problem drinking (eg, up to three-fold) and cocaine (eg, up to twice) in increasing sex risk behavior. They demonstrate the utility of distinguishing between partner types and presence/absence of alcohol/drugs during sex. Findings argue for the need to integrate sex risk reduction into drug treatment.

Entities:  

Mesh:

Year:  2015        PMID: 26501786      PMCID: PMC4779311          DOI: 10.1097/ADM.0000000000000162

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  38 in total

Review 1.  Initial clinical assessment and management of HIV infection.

Authors:  J A DeHovitz; R Sadovsky
Journal:  Prim Care       Date:  1992-03       Impact factor: 2.907

Review 2.  Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention.

Authors:  B C Leigh; R Stall
Journal:  Am Psychol       Date:  1993-10

3.  The relationship of alcohol use to sexual activity in a U.S. national sample.

Authors:  B C Leigh; M T Temple; K F Trocki
Journal:  Soc Sci Med       Date:  1994-12       Impact factor: 4.634

4.  The drug abuse screening test.

Authors:  H A Skinner
Journal:  Addict Behav       Date:  1982       Impact factor: 3.913

5.  The trading of sex for money or drugs, sexually transmitted diseases (STDs), and HIV-related risk behaviors among multisubstance using alcoholic inpatients.

Authors:  M Windle
Journal:  Drug Alcohol Depend       Date:  1997-12       Impact factor: 4.492

6.  Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Raul N Mandler; Louise Haynes; Susan Tross; Tiffany Kyle; Dianne Gallup; Andrzej S Kosinski; Antoine Douaihy; Bruce R Schackman; Moupali Das; Robert Lindblad; Sarah Erickson; P Todd Korthuis; Steve Martino; James L Sorensen; José Szapocznik; Rochelle Walensky; Bernard Branson; Grant N Colfax
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

7.  A 2-year longitudinal analysis of the relationships between violent assault and substance use in women.

Authors:  D G Kilpatrick; R Acierno; H S Resnick; B E Saunders; C L Best
Journal:  J Consult Clin Psychol       Date:  1997-10

8.  Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team.

Authors:  B R Edlin; K L Irwin; S Faruque; C B McCoy; C Word; Y Serrano; J A Inciardi; B P Bowser; R F Schilling; S D Holmberg
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

9.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

10.  The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.

Authors:  J Astemborski; D Vlahov; D Warren; L Solomon; K E Nelson
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

View more
  3 in total

1.  Associations of Drug Use, Violence, and Depressive Symptoms with Sexual Risk Behaviors Among Women with Alcohol Misuse.

Authors:  Kristen Lee; Heidi E Hutton; Catherine R Lesko; Anne K Monroe; Anika Alvanzo; Mary E McCaul; Geetanjali Chander
Journal:  Womens Health Issues       Date:  2018-05-18

2.  Longitudinal predictors of male sexual partner risk among Black and Latina women in their late thirties: ethnic/racial identity commitment as a protective factor.

Authors:  Kerstin Pahl; Ariadna Capasso; Helen-Maria Lekas; Jung Yeon Lee; Jewel Winters; Rafael E Pérez-Figueroa
Journal:  J Behav Med       Date:  2020-09-23

3.  Preoperative screening for illicit drug use in patients undergoing emergency surgery: A prospective observational study.

Authors:  Jingyi Li; He Ma; Ren Liao; Yanjuan Huang; Guiyong Chen
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.